Evidence map›Paper›PMID 39077110›Full record

ReviewFrontiers in cardiovascular medicine2024

Artificial intelligence-enabled atrial fibrillation detection using smartwatches: current status and future perspectives.

Zoi Papalamprakopoulou, Dimitrios Stavropoulos, Serafeim Moustakidis, Dimitrios Avgerinos, Michael Efremidis, Polydoros N Kampaktsis

Abstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026
    Review
  6. Review
  7. Review
  8. Observational
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zoi PapalamprakopoulouDepartment of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, United States.
Dimitrios StavropoulosDepartment of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Serafeim MoustakidisAiDEAS, Tallinn, Estonia.
Dimitrios AvgerinosOnassis Cardiac Surgery Center, Athens, Greece.
Michael EfremidisOnassis Cardiac Surgery Center, Athens, Greece.
Polydoros N KampaktsisDepartment of Medicine, Aristotle University of Thessaloniki Medical School, Thessaloniki, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation (AF) significantly increases the risk of stroke and heart failure, but is frequently asymptomatic and intermittent; therefore, its timely diagnosis poses challenges. Early detection in selected patients may aid in stroke prevention and mitigate structural heart complications through prompt intervention. Smartwatches, coupled with powerful artificial intelligence (AI)-enabled algorithms, offer a promising tool for early detection due to their widespread use, easiness of use, and potential cost-effectiveness. Commercially available smartwatches have gained clearance from the FDA to detect AF and are becoming increasingly popular. Despite their promise, the evolving landscape of AI-enabled smartwatch-based AF detection raises questions about the clinical value of this technology. Following the ongoing digital transformation of healthcare, clinicians should familiarize themselves with how AI-enabled smartwatches function in AF detection and navigate their role in clinical settings to deliver optimal patient care. In this review, we provide a concise overview of the characteristics of AI-enabled smartwatch algorithms, their diagnostic performance, clinical value, limitations, and discuss future perspectives in AF diagnosis.

Indexed as

artificial intelligenceatrial fibrillationmachine learningphotoplethysmographysingle-lead electrocardiographysmartwatches

Identifiers

PMID39077110
PMCPMC11284169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.